Used in research for its potent and selective inhibition of the c-Met kinase pathway, which plays a key role in tumor growth and metastasis. Shows promise in preclinical studies for targeting cancers with c-Met dysregulation, including certain lung, gastric, and liver cancers. Investigated for its ability to suppress tumor cell proliferation, reduce invasion, and induce apoptosis in c-Met-dependent cancer models. Also employed as a pharmacological tool to study signaling pathways involving hepatocyte growth factor (HGF) and c-Met interactions. Not approved for clinical use; currently limited to laboratory and experimental settings.